In Berger Montague Whistleblower Case, Janssen Found Liable for Illegal Off-Label Promotion and Marketing of Two HIV/AIDS-Treatment Drugs – Judgment Could Exceed $1B

PHILADELPHIA, June 17, 2024 /PRNewswire/ — Berger Montague PC is pleased to announce that on June 13, 2024, a jury unanimously found Johnson & Johnson subsidiary Janssen Products, LP liable for illegal off-label promotion and marketing of two of its HIV/AIDS-treatment drugs, in violation…

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.